Randomized placebo-controlled trial of the bradykinin B₂ receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial.


Abstract

Clinicaltrials.gov Identifier: NCT00912093.


Full Text


Subjects


Similar articles

Authors


Publication date

2011-11-29


Journal

Annals of allergy, asthma & immunology
Ann Allergy Asthma Immunol (1534-4436)

Journal topics


Language

Eng.


Copyright

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology

Allergy and Asthma Research Associates Research Center, Dallas, Texas 75081, USA. LumryMD [at] AllergySpecialists.us


Release reference

Ann Allergy Asthma Immunol. 2011 Dec;107(6):529-37



Related books


Español | English

© Galenicom 1999-2013